ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989

Budget Cuts Delay New Cooperative Drug Discovery Groups For Lung, Colon Cancer At Least One Year

February 21, 1986

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

Requiring Survival Data Was Logical In 1950s, Not Today, Broder Says

January 13, 1989

NCAB Considers Discrimination Against Patients, Minority Rates, Smokeless Tobacco

April 12, 1985

Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer

July 27, 2001